Stay updated on Nivolumab for Uterine Cancer - Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.

Latest updates to the Nivolumab for Uterine Cancer - Clinical Trial page
- Check6 days agoChange DetectedRemoved the site-wide notice about government funding and NIH operations; core study details and links remain unchanged.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNo additions or deletions were detected between the two screenshots. The page content remains unchanged.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check55 days agoChange DetectedUpdated medical term from Endometrioid stromal sarcoma to Endometrial stromal sarcoma and bumped revision from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check70 days agoChange DetectedRevision: v3.0.2 added and the 'Back to Top' option removed.SummaryDifference0.2%

- Check77 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

Stay in the know with updates to Nivolumab for Uterine Cancer - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Uterine Cancer - Clinical Trial page.